Indian pharmaceutical stocks came under broad selling pressure on Wednesday after US President Donald Trump unveiled a phased tariff roadmap for imported generic medicines, sparking concerns over the long-term outlook for Indian drugmakers that rely heavily on the world's largest pharmaceutical market.
Trump's Tariffs Will Start In 2028; So Why Are Pharma Stocks Falling Today?
Indian drugmakers have until 2028 before proposed US tariffs on generic medicines take effect, but investors are already weighing the long-term impact on export margins, manufacturing strategies and the sector's growth outlook
Summary
Published At:
Tags